Hellewell JS - Search Results

1

Differing tolerability profiles among atypical antipsychotics.

Hellewell JS, Haddad PM. Hellewell JS, et al. Am J Psychiatry. 2001 Mar;158(3):501-2. doi: 10.1176/appi.ajp.158.3.501. Am J Psychiatry. 2001. PMID: 11230007 No abstract available.

2

Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports.

Haddad PM, Hellewell JS, Wieck A. Haddad PM, et al. Among authors: hellewell js. J Psychopharmacol. 2001 Dec;15(4):293-5. doi: 10.1177/026988110101500408. J Psychopharmacol. 2001. PMID: 11769824

3

Further comments on Jerusalem syndrome.

Hellewell JS, Haddad PM. Hellewell JS, et al. Br J Psychiatry. 2000 Jun;176:594. doi: 10.1192/bjp.176.6.594-a. Br J Psychiatry. 2000. PMID: 10974969 No abstract available.

4

Treatment-resistant schizophrenia: reviewing the options and identifying the way forward.

Hellewell JS. Hellewell JS. J Clin Psychiatry. 1999;60 Suppl 23:14-9. J Clin Psychiatry. 1999. PMID: 10625195 Review.

5

The health economic implications of treatment with quetiapine: an audit of long-term treatment for patients with chronic schizophrenia.

Lynch J, Morrison J, Graves N, Meddis D, Drummond MF, Hellewell JS. Lynch J, et al. Among authors: hellewell js. Eur Psychiatry. 2001 Aug;16(5):307-12. doi: 10.1016/s0924-9338(01)00583-1. Eur Psychiatry. 2001. PMID: 11514134

6

Quetiapine: a well-tolerated and effective atypical antipsychotic.

Hellewell JS. Hellewell JS. Hosp Med. 2002 Oct;63(10):600-3. doi: 10.12968/hosp.2002.63.10.1931. Hosp Med. 2002. PMID: 12422494 Review.

7

Managing the aftermath of mania - Newcastle, 2 September 2005: Consensus Meeting Statement.

Young AH, Cookson J, Elliott B, Hellewell JS, McAllister-Williams RH, Newham J, Ogilvie A, Scott J, Tyrer S, Turner M. Young AH, et al. Among authors: hellewell js. J Psychopharmacol. 2006 Mar;20(2 Suppl):51-4. doi: 10.1177/1359786806063079. J Psychopharmacol. 2006. PMID: 16551673 No abstract available.

8

Comparison of buspirone with diazepam and fluvoxamine on aversive classical conditioning in humans.

Hellewell JS, Guimaraes FS, Wang M, Deakin JF. Hellewell JS, et al. J Psychopharmacol. 1999;13(2):122-7. doi: 10.1177/026988119901300202. J Psychopharmacol. 1999. PMID: 10475716 Clinical Trial.

9

Patients' subjective experiences of antipsychotics: clinical relevance.

Hellewell JS. Hellewell JS. CNS Drugs. 2002;16(7):457-71. doi: 10.2165/00023210-200216070-00003. CNS Drugs. 2002. PMID: 12056921 Review.

10

Characterization of a psychophysiological model of classical fear conditioning in healthy volunteers: influence of gender, instruction, personality and placebo.

Guimarães FS, Hellewell J, Hensman R, Wang M, Deakin JF. Guimarães FS, et al. Psychopharmacology (Berl). 1991;104(2):231-6. doi: 10.1007/BF02244184. Psychopharmacology (Berl). 1991. PMID: 1876667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters